Arbutus Biopharma Corp·4

Apr 18, 2:25 PM ET

Sofia Michael J. 4

4 · Arbutus Biopharma Corp · Filed Apr 18, 2018

Insider Transaction Report

Form 4
Period: 2018-04-16
Sofia Michael J.
Chief Scientific Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-04-16+160,000160,000 total
    Exercise: $5.20Exp: 2028-04-16Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]The options vest as follows: 1/3 on April 16, 2019; 1/3 on April 16, 2020; and 1/3 on April 16, 2021.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4